Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-63 (IGHV3-63) is classified as a pseudogene located within the immunoglobulin heavy chain locus on chromosome 14. Like other members of the IGHV family, functional IGHV genes encode the variable region of the heavy chain in immunoglobulins (antibodies), which is critical for antigen recognition and adaptive immune response. However, as a pseudogene, IGHV3-63 is not transcribed into a functional protein and does not participate directly in antibody synthesis or immune function[3][6][7]. The presence of such pseudogenes reflects the evolutionary history and diversification of the immunoglobulin gene superfamily, but they are not considered actionable targets for drugs or therapeutics. IGHV3-63 is not a functional immunoglobulin variable gene but is annotated as a pseudogene in multiple genomic and biomedical information systems; hence it is not a therapeutic target or biomarker[3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-63 (pseudogene) (IGHV3-63).